BlackRock Investment Management’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$3.78M Buy
77,137
+13,336
+21% +$653K ﹤0.01% 1782
2016
Q3
$3.05M Sell
63,801
-106
-0.2% -$5.07K ﹤0.01% 1837
2016
Q2
$3.43M Buy
63,907
+3,568
+6% +$191K ﹤0.01% 1705
2016
Q1
$2.7M Buy
60,339
+951
+2% +$42.5K ﹤0.01% 1787
2015
Q4
$2.27M Buy
59,388
+352
+0.6% +$13.4K ﹤0.01% 1984
2015
Q3
$1.88M Sell
59,036
-554
-0.9% -$17.6K ﹤0.01% 2115
2015
Q2
$1.97M Buy
59,590
+8,994
+18% +$297K ﹤0.01% 2245
2015
Q1
$2.08M Buy
50,596
+727
+1% +$29.9K ﹤0.01% 1990
2014
Q4
$2.03M Sell
49,869
-266
-0.5% -$10.8K ﹤0.01% 2024
2014
Q3
$1.84M Buy
50,135
+1,949
+4% +$71.5K ﹤0.01% 2055
2014
Q2
$2.23M Buy
48,186
+5,539
+13% +$257K ﹤0.01% 1992
2014
Q1
$1.75M Buy
42,647
+237
+0.6% +$9.74K ﹤0.01% 2113
2013
Q4
$1.62M Buy
42,410
+5,354
+14% +$204K ﹤0.01% 2155
2013
Q3
$885K Buy
37,056
+930
+3% +$22.2K ﹤0.01% 2524
2013
Q2
$614K Buy
+36,126
New +$614K ﹤0.01% 2713